Rose SR, Lustig RH, Burstein S., Pitukcheewanont P., Broome DC, Burghen GADiagnosis of ACTH deficiency. Comparison of overnight metyrapone test to either low-dose or high-dose ACTH test. Horm Res. 1999;52:73-79.
2.
Allen DBEffects of inhaled steroids on growth, bone metabolism, and adrenal function . Adv Pediatr. 2006;53: 101-110.
3.
Shenoy SD, Swift PG, Cody D.Growth impairment and adrenal suppression on low-dose inhaled beclomethasone . J Paediatr Child Health. 2006;42:143-144.
4.
Paton J., Jardine E., McNeill E., et al. Adrenal responses to low dose synthetic ACTH (Synacthen) in children receiving high dose inhaled fluticasone. Arch Dis Child. 2006;91:808-813.
5.
Dunlop KA, Carson DJ, Steen HJ, McGovern V., McNaboe J., Shields MDMonitoring growth in asthmatic children treated with high dose inhaled glucocorticoids does not predict adrenal suppression. Arch Dis Child. 2004;89:713-716.
6.
Agertoft L., Pedersen S.Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med. 2000;343:1064-1069.
7.
Long-term effects of budesonide or nedocromil in children with asthma. The Childhood Asthma Management Program Research Group. N Engl J Med. 2000;343:1054-1063.
8.
Arend EE, Fischer GB, Mocelin H., Medeiros L.Inhaled corticosteroids: effects on growth and adrenal suppression. J Bras Pneumol. 2005;31:341-349.
9.
Brodlie M., Spencer D.Growth recovery after withdrawal of inappropriate inhaled fluticasone proprionate . Pediatr Pulmonol. 2008;43:307-308.
10.
Wong JY, Zacharin MR, Hocking N., Robinson PJGrowth and adrenal suppression in asthmatic children on moderate to high doses of fluticasone propionate. J Paediatr Child Health. 2002;38:59-62.
11.
Pearce RE, Leeder JS, Kearns GLBiotransformation of fluticasone: in vitro characterization. Drug Metab Dispos. 2006;34:1035-1040.
12.
Foisy MM, Yakiwchuk EM, Chiu I., Singh AEAdrenal suppression and Cushing’s syndrome secondary to an interaction between ritonavir and fluticasone: a review of the literature. HIV Med. 2008;9:389-396.
